EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Conjunctival transcriptomics in ocular mucous membrane pemphigoid

Jesse Panthagani, Kusy Suleiman, Rachel C Vincent, Hon Shing Ong, Graham R Wallace, Saaeha Rauz

The Ocular Surface · 2023-10 · 30 · 142-149

DOI: 10.1016/j.jtos.2023.09.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Ocular Surface, 2023-10. Verfasst von Jesse Panthagani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, UK; Birmingham and Midland Eye Centre, Sandwell and W…. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Pemphigoid, Benign Mucous Membrane, Conjunctivitis, Conjunctival Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Sight Research UK, Fight for Sight UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Ocular Mucous Membrane Pemphigoid (OcMMP) is an orphan disease characterized by chronic autoimmune-driven conjunctival inflammation leading to progressive scarring, debilitating symptoms, and blinding sequelae. This feasibility study aims to demonstrate conjunctival genetic transcriptomic analyses as a putative tool for interrogation of pathogenic signaling pathways in OcMMP. METHODS: Conjunctival RNA profiling using the NanoString nCounter Human Fibrosis panel was undertaken on RNA extracted from conjunctival swabs obtained from 6 MMP patients (8 eyes; 4 M/2F; median age 78 [range 64-84] years); and 8 age-matched control participants (15 eyes; 3 M/5F; median age 69.5 [range 69-88] years). Data from 770 genes were analyzed with ROSALIND HyperScale architecture and stratified according to the level of clinically visible bulbar conjunctival inflammation. Normalization, fold-changes (≥+1.5-fold or ≤ -1.5-fold) and p-values adjustment (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousPemphigoid, Benign Mucous MembraneConjunctivitisConjunctival DiseasesHumansMiddle AgedAgedAged, 80 and overConjunctivaFibrosisInflammationMucous MembraneGene Expression ProfilingRNA

Stichwörter der Autor:innen

ALDH1A3FibrosisInflammationNanoStringScarring

Substanzen

RNA

Autor:innen und Institutionen

  • Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, UK; Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK.
  • Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, UK.
  • Tissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore; Corneal and External Diseases Department, Singapore National Eye Centre, Singapore, Singapore; Ophthalmology & Visual Sciences Acad…
  • Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, UK; Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK. Electronic address: s.rauz@b…

Förderung

  • Medical Research Council
  • Sight Research UK
  • Fight for Sight UK
  • UK Research and Innovation
  • UKRI Medical Research Council

Zitieren

APA

Panthagani, J., Suleiman, K., Vincent, R. C., Ong, H. S., Wallace, G. R., & Rauz, S. (2023). Conjunctival transcriptomics in ocular mucous membrane pemphigoid. The Ocular Surface, 30, 142-149. https://doi.org/10.1016/j.jtos.2023.09.005

Vancouver

Panthagani J, Suleiman K, Vincent RC, Ong HS, Wallace GR, Rauz S. Conjunctival transcriptomics in ocular mucous membrane pemphigoid. The Ocular Surface. 2023;30:142-149. doi:10.1016/j.jtos.2023.09.005

BibTeX
@article{Panthagani2023,
  author = {Panthagani, Jesse and Suleiman, Kusy and Vincent, Rachel C and Ong, Hon Shing and Wallace, Graham R and Rauz, Saaeha},
  title = {Conjunctival transcriptomics in ocular mucous membrane pemphigoid},
  journal = {The Ocular Surface},
  year = {2023},
  volume = {30},
  pages = {142--149},
  doi = {10.1016/j.jtos.2023.09.005}
}
Kostenlos starten →